HomeAVBP • NASDAQ
add
Arrivent Biopharma Inc
Previous close
$24.69
Day range
$24.60 - $25.82
Year range
$15.47 - $29.86
Market cap
1.03B USD
Avg Volume
367.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.32M | 58.12% |
Net income | -34.75M | -68.99% |
Net profit margin | — | — |
Earnings per share | -0.83 | -36.07% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 300.27M | 6.16% |
Total assets | 326.56M | 11.56% |
Total liabilities | 21.56M | 41.66% |
Total equity | 305.00M | — |
Shares outstanding | 41.28M | — |
Price to book | 3.31 | — |
Return on assets | -32.14% | — |
Return on capital | -34.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -34.75M | -68.99% |
Cash from operations | -35.80M | -119.01% |
Cash from investing | -50.76M | — |
Cash from financing | 86.46M | 16,183.43% |
Net change in cash | -93.00K | 99.41% |
Free cash flow | -24.76M | -126.68% |
About
Founded
2021
Headquarters
Website
Employees
52
